Software, ICP/MS, ICP/MS/MS
IndustriesManufacturerAgilent Technologies
Significance of the Topic
Electronic records and signatures are crucial in regulated laboratories to guarantee data security, integrity and traceability. Regulatory frameworks such as FDA 21 CFR Part 11 and EU Annex 11 impose rigorous controls on analytical instruments and their software to ensure reliable documentation of methods, raw data and analytical reports. Compliance with these standards is mandatory in pharmaceutical, food safety and other highly regulated industries.
Objectives and Overview of the Study
This white paper describes how Agilent’s Spectroscopy Database Administrator (SDA) module integrated with ICP-MS MassHunter enables laboratories using Agilent ICP-MS and ICP-QQQ systems to achieve compliance with 21 CFR Part 11 and EU Annex 11. It compares compliance solutions for small to large labs, highlights the SDA option for single-instrument workstations, and outlines the four key compliance components: design qualification, secure user access and audit trails, electronic record management, and operational performance checks.
Methodology and Instrumentation
The solution is built around:
- Agilent ICP-MS and ICP-QQQ instruments controlled by MassHunter software
- SDA module installed locally to capture, store and manage electronic records
- User Access Control via OpenLab Shared Services for password-protected multi-level permissions and audit trails
- Optional OpenLab ECM, Server or ECM XT for larger multi-instrument environments
The compliance strategy includes Design Qualification (DQ), Installation and Operational Qualification (IQ/OQ), System Suitability Testing (SST) and SOPs for routine performance checks under USP<232> and ICH Q3D.
Main Results and Discussion
Agilent has validated both ICP-MS MassHunter and SDA modules under its internal Quality Management System, providing Declaration of Product Validation and IQ/OQ documentation.
- SDA captures raw data, metadata, audit trails and reports, storing them in a secure Microsoft SQL Server Express database.
- Audit trails record all user actions with timestamp, user ID and reason for changes, meeting ALCOA+ principles.
- Electronic signatures require two-factor authentication and are permanently linked to records.
- Backup, retrieval and data integrity checks are supported by SDA, with user-defined backup schedules and database protection modes.
Compliance requirements such as authorized user management, operational and device checks, system performance verification and controlled documentation are satisfied or supported with appropriate recommendations for user responsibilities.
Benefits and Practical Applications
The integrated SDA-MassHunter solution offers:
- Cost-effective compliance for small to medium labs without extensive server infrastructure
- End-to-end workflow support from instrument control to data archival
- Robust data integrity, audit trail and electronic signature capabilities
- Scalability to multi-instrument and multi-site deployments when combined with OpenLab ECM or Server
Laboratories can streamline regulatory audits and reduce manual data handling while ensuring secure, traceable record-keeping.
Future Trends and Opportunities
Emerging trends include cloud-based data management, enhanced AI-driven data analytics and further integration of digital lab notebooks. Future enhancements could expand remote monitoring, machine learning–based anomaly detection and blockchain-enabled audit trails to strengthen data integrity in distributed laboratory networks.
Conclusion
Agilent’s SDA module for ICP-MS MassHunter delivers a practical, validated approach to meeting 21 CFR Part 11 and EU Annex 11 requirements on a single-workstation basis. With its comprehensive audit trail, electronic signature and secure database features, it supports laboratories in regulated industries to maintain compliance, improve data integrity and optimize workflow efficiency.
Reference
Support for 21 CFR Part 11 and Annex 11 Compliance: SDA Module for Agilent ICP-MS MassHunter Software, Agilent Technologies, White Paper, March 2021.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.